Akums is India’s single largest Contract Research and Manufacturing (CRAMS) organization responsible for manufacturing approximately 11-12 % of all drugs consumed in the country. The organization offers a comprehensive range of services starting from formulation development to market launch all en suite.
Contract Research & Manufacturing Services (CRAMS),
Formulation & development of Novel Drugs Delivery Systems (N.D.D.S.),
Loan License,
New Formulations with DCGI Approvals,
Institutional business
Technology Transfer,
Technical collaboration and Joint venture,
Akums 9 state of the art facilities are equipped to produce all modern dosage forms — tablets, hard gelatin capsules, soft gelatin capsules, powder in sachets, liquid syrups and suspensions, injections, eye/ear drops, ointments, creams, gels, lotions, ayurveda and herbal preparations, nutraceutical and cosmetic preparations and many more. Akums offers significant manufacturing capacities, offering:
• 119.65 Million Tablets,
• 19.47 Million Hard Gelatin Capsules
• 3.19 Soft Gelatin Capsules
• 2.01 Liquid Orals
• 1.83 Sachets
• 1.46 Vials
• 1.07 Ampoules
• 0.65 FFS
• 0.61 Topical Preparations
• 0.3 3-Piece Eye Nasal Drops
Akums has emerged as an integrated solution provider for companies seeking specific development and business goals. Along with its core service offering, the company offers advanced solutions for formulation development and testing. Akums total revenue stood at more than INR 21 Billion in the financial year 2016-17, growing at a rate of more than 20% over the past year
